U.S. Markets open in 4 hrs 17 mins
  • Gold

    1,764.30
    -4.00 (-0.23%)
     
  • EUR/USD

    1.1586
    -0.0015 (-0.1274%)
     
  • 10-Yr Bond

    1.5760
    +0.0570 (+3.75%)
     
  • Vix

    17.40
    +0.54 (+3.20%)
     
  • GBP/USD

    1.3724
    +0.0047 (+0.3472%)
     
  • USD/JPY

    114.3550
    +0.6780 (+0.5964%)
     
  • BTC-USD

    61,745.21
    +955.68 (+1.57%)
     
  • CMC Crypto 200

    1,446.76
    +40.02 (+2.84%)
     
  • FTSE 100

    7,216.59
    -17.44 (-0.24%)
     
  • Nikkei 225

    29,025.46
    +474.56 (+1.66%)
     

Is Now An Opportune Moment To Examine DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) saw a significant share price rise of over 20% in the past couple of months on the NASDAQGS. With many analysts covering the large-cap stock, we may expect any price-sensitive announcements have already been factored into the stock’s share price. However, what if the stock is still a bargain? Let’s examine DENTSPLY SIRONA’s valuation and outlook in more detail to determine if there’s still a bargain opportunity.

View our latest analysis for DENTSPLY SIRONA

What is DENTSPLY SIRONA worth?

According to my valuation model, DENTSPLY SIRONA seems to be fairly priced at around 1.9% below my intrinsic value, which means if you buy DENTSPLY SIRONA today, you’d be paying a reasonable price for it. And if you believe that the stock is really worth $57.36, then there isn’t much room for the share price grow beyond what it’s currently trading. What's more, DENTSPLY SIRONA’s share price may be more stable over time (relative to the market), as indicated by its low beta.

What does the future of DENTSPLY SIRONA look like?

earnings-and-revenue-growth
earnings-and-revenue-growth

Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. DENTSPLY SIRONA's revenue growth are expected to be in the teens in the upcoming years, indicating a solid future ahead. Unless expenses grow at the same level, or higher, this top-line growth should lead to robust cash flows, feeding into a higher share value.

What this means for you:

Are you a shareholder? XRAY’s optimistic future growth appears to have been factored into the current share price, with shares trading around its fair value. However, there are also other important factors which we haven’t considered today, such as the financial strength of the company. Have these factors changed since the last time you looked at the stock? Will you have enough conviction to buy should the price fluctuates below the true value?

Are you a potential investor? If you’ve been keeping an eye on XRAY, now may not be the most advantageous time to buy, given it is trading around its fair value. However, the positive outlook is encouraging for the company, which means it’s worth diving deeper into other factors such as the strength of its balance sheet, in order to take advantage of the next price drop.

Since timing is quite important when it comes to individual stock picking, it's worth taking a look at what those latest analysts forecasts are. At Simply Wall St, we have the analysts estimates which you can view by clicking here.

If you are no longer interested in DENTSPLY SIRONA, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.